Cargando…

Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway

The development of ivermectin as a complementary vector control tool will require good quality evidence. This paper reviews the different eco-epidemiological contexts in which mass drug administration with ivermectin could be useful. Potential scenarios and pharmacological strategies are compared in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaccour, Carlos, Rabinovich, N. Regina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402168/ https://www.ncbi.nlm.nih.gov/pubmed/28434405 http://dx.doi.org/10.1186/s12936-017-1802-3

Ejemplares similares

Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways
por: Chaccour, Carlos, et al.
Publicado: (2017)

Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
por: Chaccour, Carlos, et al.
Publicado: (2017)

Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
por: Chaccour, Carlos, et al.
Publicado: (2020)

Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination
por: Chaccour, Carlos J, et al.
Publicado: (2013)

Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda
por: Chaccour, Carlos J, et al.
Publicado: (2015)

Potential impact of 5 years of ivermectin mass drug administration on malaria outcomes in high burden countries
por: Marathe, Achla, et al.
Publicado: (2021)

Ivermectin treatment in humans for reducing malaria transmission
por: Souza, Dziedzom K, et al.
Publicado: (2021)

Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis
por: Nicolas, Patricia, et al.
Publicado: (2020)

BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa—a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings
por: Chaccour, Carlos, et al.
Publicado: (2023)

Screening for an ivermectin slow-release formulation suitable for malaria vector control
por: Chaccour, Carlos, et al.
Publicado: (2015)

Mapping the potential use of endectocide-treated cattle to reduce malaria transmission
por: Imbahale, Susan S., et al.
Publicado: (2019)

Mind the gap: residual malaria transmission, veterinary endectocides and livestock as targets for malaria vector control
por: Chaccour, Carlos, et al.
Publicado: (2016)

Effects of larval exposure to sublethal doses of ivermectin on adult fitness and susceptibility to ivermectin in Anopheles gambiae s.s.
por: Kiuru, Caroline, et al.
Publicado: (2023)

A field bioassay for assessing ivermectin bio-efficacy in wild malaria vectors
por: Ominde, Kelly M., et al.
Publicado: (2023)

The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial
por: Chaccour, Carlos, et al.
Publicado: (2020)

Ivermectin and malaria control
por: Ōmura, Satoshi, et al.
Publicado: (2017)

The effect of ivermectin alone and in combination with cobicistat or elacridar in experimental Schistosoma mansoni infection in mice
por: Vicente, Belén, et al.
Publicado: (2021)

Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes
por: Kern, Charlotte, et al.
Publicado: (2023)

The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes
por: Duthaler, Urs, et al.
Publicado: (2021)

Building momentum for malaria vaccine research and development: key considerations
por: Chitnis, Chetan E., et al.
Publicado: (2020)

Targeting cattle for malaria elimination: marked reduction of Anopheles arabiensis survival for over six months using a slow-release ivermectin implant formulation
por: Chaccour, Carlos J., et al.
Publicado: (2018)

Administration of ivermectin to peridomestic cattle: a promising approach to target the residual transmission of human malaria
por: Pooda, Hermann S., et al.
Publicado: (2015)

Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study
por: Nicolas, Patricia, et al.
Publicado: (2021)

Treatment of Pregnant Women with Ivermectin during Mass Drug Distribution: Time to Investigate Its Safety and Potential Benefits
por: Erber, Astrid Christine, et al.
Publicado: (2021)

Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments
por: Alout, Haoues, et al.
Publicado: (2014)

Promising approach to reducing Malaria transmission by ivermectin: Sporontocidal effect against Plasmodium vivax in the South American vectors Anopheles aquasalis and Anopheles darlingi
por: Pinilla, Yudi T., et al.
Publicado: (2018)

Incidental mosquitocidal effect of an ivermectin mass drug administration on Anopheles farauti conducted for scabies control in the Solomon Islands
por: Kositz, Christian, et al.
Publicado: (2017)

A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool
Publicado: (2020)

PBPK modeling of ivermectin—Considerations for the purpose of developing alternative routes to optimize its safety profile
por: Rowland Yeo, Karen, et al.
Publicado: (2023)

Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats
por: Chaccour, Carlos, et al.
Publicado: (2020)

Ivermectin metabolites reduce Anopheles survival
por: Kobylinski, Kevin C., et al.
Publicado: (2023)

The economic burden of malaria on households and the health system in a high transmission district of Mozambique
por: Alonso, Sergi, et al.
Publicado: (2019)

Drugs that reduce transmission of falciparum malaria
por: Price, Ric N, et al.
Publicado: (2018)

BOHEMIA a cluster randomized trial to assess the impact of an endectocide-based one health approach to malaria in Mozambique: baseline demographics and key malaria indicators
por: Ruiz-Castillo, Paula, et al.
Publicado: (2023)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Ivermectin and Malaria—Putting an Elderly Drug to a New Test
por: Campbell, William C.
Publicado: (2020)

Clinical neuropsychiatric considerations regarding nonsubstance or behavioral addictions
por: Potenza, Marc N.
Publicado: (2017)

Reducing Malaria Transmission in Africa
Publicado: (2005)

Burden and risk factors of snakebite in Mopeia, Mozambique: Leveraging larger malaria trials to generate data of this neglected tropical disease
por: O’Bryan, Emma, et al.
Publicado: (2023)

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
por: Chaccour, Carlos, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ckopvsmhseneg3sb8ldmi3idhv